Cargando…

Cystatin C as a Promising Biomarker of Atherosclerotic Plaque

Detalles Bibliográficos
Autor principal:	Sawada, Shojiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193781/ https://www.ncbi.nlm.nih.gov/pubmed/32908036 http://dx.doi.org/10.5551/jat.ED140

Ejemplares similares

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Association of serum cystatin C level with coronary atherosclerotic plaque burden: a comprehensive analysis of observational studies and genetic study
por: Chen, Jun, et al.
Publicado: (2023)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Discrepant changes of urinary cystatin C and other urinary biomarkers in preterm neonates()
por: Filler, Guido, et al.
Publicado: (2021)

Serum Cystatin C Level as a Biomarker of Aortic Plaque in Patients with an Aortic Arch Aneurysm
por: Nishimura, Yoshiharu, et al.
Publicado: (2021)

Sonodynamic Therapy of Atherosclerotic Plaques: Breaking the Cycle
por: Ziegler, Tilman, et al.
Publicado: (2020)

Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

Proteomic analyses reveal cystatin c is a promising biomarker for evaluation of systemic lupus erythematosus
por: Huang, He, et al.
Publicado: (2023)

Cystatin C–Adiponectin Complex in Plasma Associates with Coronary Plaque Instability
por: Matsumoto, Akane, et al.
Publicado: (2017)

Cystatin C: not just a marker of kidney function
por: Fernando, Sanduni, et al.
Publicado: (2020)

Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis
por: González-Gay, Miguel A, et al.
Publicado: (2012)

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors
por: Wang, Hui, et al.
Publicado: (2018)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis
por: Benndorf, Ralf A.
Publicado: (2018)

Identification of immune infiltration-related biomarkers in carotid atherosclerotic plaques
por: Zheng, Kai, et al.
Publicado: (2023)

Therapeutic Effect of Schistosoma japonicum Cystatin on Atherosclerotic Renal Damage
por: Yang, Huijuan, et al.
Publicado: (2021)

Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality
por: de Carvalho, Luiz Sérgio F., et al.
Publicado: (2018)

Cystatin C in pregnant women is not a simple kidney filtration marker
por: Lee, Hajeong
Publicado: (2018)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption
por: Lee, Regent, et al.
Publicado: (2017)

Activation of the Non-receptor Tyrosine Kinase cSrc in Macrophage-rich Atherosclerotic Plaques of Human Carotid Arteries
por: Toi, Sono, et al.
Publicado: (2007)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Is size really all that matters? Remarks on size and necrotic core content of atherosclerotic plaques
por: von Birgelen, Clemens, et al.
Publicado: (2009)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
por: McGarrah, Robert W., et al.
Publicado: (2022)

Complement factor C5a induces atherosclerotic plaque disruptions
por: Wezel, Anouk, et al.
Publicado: (2014)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients
por: Jeon, Eon Ju, et al.
Publicado: (2016)

The Elusive Origin of Atherosclerotic Plaque Calcification
por: Canet-Soulas, Emmanuelle, et al.
Publicado: (2021)

Clinical Molecular Imaging for Atherosclerotic Plaque
por: Kondakov, Anton, et al.
Publicado: (2021)

Cellular crosstalk in atherosclerotic plaque microenvironment
por: Mahdinia, Elmira, et al.
Publicado: (2023)

Residual risks and evolving atherosclerotic plaques
por: Noothi, Sunil K., et al.
Publicado: (2023)

Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Wilson, Meghan E., et al.
Publicado: (2010)

The potential of cystatin C as a predictive biomarker in pulmonary hypertension
por: Duan, Anqi, et al.
Publicado: (2023)

Radiofrequency Ablation of the Atherosclerotic Plaque: a Proof of Concept Study in an Atherosclerotic Model
por: Ellenbroek, Guilielmus H.J.M., et al.
Publicado: (2017)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rqb4t3e0oroipbev7kudjrr3po